The reconstitution of the thymus in immunosuppressed individuals restores CD4-specific cellular and humoral immune responses

Immunology

Volumn 133, Issue 3, 2011, Pages 318-328

  Plana, Montserrat ^a   Garcia, Felipe ^a   Darwich, Laila ^b,c   Romeu, Joan ^c,d   López, Anna ^a   Cabrera, Cecilia ^b   Massanella, Marta ^b   Canto, Esther ^b   Ruiz Hernandez, Raul ^e   Blanco, Julià ^b,f   Sánchez, Marcelo ^g   Gatell, Josep M ^a   Clotet, Bonaventura ^b,d   Ruiz, Lidia ^b   Bofill, Margarita ^b,h  

^a UNIVERSITY OF BARCELONA   (Spain)

^b IrsiCaixa Foundation   (Spain)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^d Fundació de Lluita Contral la SIDA   (Spain)

^e INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

^f AIDS Research Institute IrsiCaixa   (Spain)

^g HOSPITAL CLÍNIC   (Spain)

^h INSTITUCIÓ CATALANA DE RECERCA I ESTUDIS AVANÇATS ICREA   (Spain)

Author keywords

Adjuvant; Cellular responses; Growth hormone; HIV; Humoral responses; Thymus

Indexed keywords

CD4 ANTIGEN; CD45RA ANTIGEN; CD45RO ANTIGEN; CD69 ANTIGEN; CD8 ANTIGEN; CHEMOKINE RECEPTOR CCR5; CHEMOKINE RECEPTOR CXCR4; CHEMOKINE RECEPTOR CXCR5; DITANRIX ADULTOS; GAG PROTEIN; HEPATITIS A HEPATITIS B VACCINE; INTERLEUKIN 2 RECEPTOR ALPHA; PADGEM PROTEIN; RECOMBINANT GROWTH HORMONE; SOMATREM; TETANUS TOXOID; TWINRIX ADULTOS; UNCLASSIFIED DRUG;

ADULT; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTHRALGIA; ARTICLE; ASTHENIA; CARPAL TUNNEL SYNDROME; CELLULAR IMMUNITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DOSE REDUCTION; HAND EDEMA; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; HUMORAL IMMUNITY; IMMUNE DEFICIENCY; MULTICENTER STUDY; MYALGIA; PERIPHERAL NEUROPATHY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RESPIRATORY TRACT INFECTION; THYMUS;

ADULT; CD4-CD8 RATIO; CD4-POSITIVE T-LYMPHOCYTES; CHEMOTHERAPY, ADJUVANT; GROWTH HORMONE; HIV INFECTIONS; HIV-1; HUMANS; IMMUNITY, CELLULAR; IMMUNITY, HUMORAL; IMMUNOCOMPROMISED HOST; ORGAN SIZE; THYMUS GLAND; VIRAL VACCINES;

EID: 79957834507     PISSN: 00192805     EISSN: 13652567     Source Type: Journal    
DOI: 10.1111/j.1365-2567.2011.03442.x     Document Type: Article

References (33)

1. + T-cell expansion in HIV-infected patients is associated with long-term decreases in T-cell proliferation. Blood 2004; 104:775-80.
2. Teixeira L, Valdez H, McCune JM et al. Poor CD4 T cell restoration after suppression of HIV-1 replication may reflect lower thymic function. Aids 2001; 15:1749-56.
3. Douek DC. The contribution of the thymus to immune reconstitution after hematopoietic stem-cell transplantation. Cytotherapy 2002; 4:425-6.
4. + cell depletion. J Infect Dis 2003; 188:1794-803.
5. Morrhaye G, Kermani H, Legros JJ et al. Impact of growth hormone (GH) deficiency and GH replacement upon thymus function in adult patients. PLoS ONE 2009; 4:e5668.
6. Berzins SP, Uldrich AP, Sutherland JS, Gill J, Miller JF, Godfrey DI, Boyd RL. Thymic regeneration: teaching an old immune system new tricks. Trends Mol Med 2002; 10:469-76.
7. Napolitano LA, Lo JC, Gotway MB et al. Increased thymic mass and circulating naive CD4 T cells in HIV-1-infected adults treated with growth hormone. Aids 2002; 16:1103-11.
8. Al-Harthi L, Landay A. Immune recovery in HIV disease: role of the thymus and T cell expansion in immune reconstitution strategies. J Hematother Stem Cell Res 2002; 11:777-86.
9. Pires A, Pido-Lopez J, Moyle G, Gazzard B, Gotch F, Imami N. Enhanced T-cell maturation, differentiation and function in HIV-1-infected individuals after growth hormone and highly active antiretroviral therapy. Antivir Ther 2004; 9:67-75.
10. Herasimtschuk AA, Westrop SJ, Moyle GJ, Downey JS, Imami N. Effects of recombinant human growth hormone on HIV-1-specific T-cell responses, thymic output and proviral DNA in patients on HAART: 48-week follow-up. J Immune Based Ther Vaccines 2008; 6:7.
11. Napolitano LA, Schmidt D, Gotway MB et al. Growth hormone enhances thymic function in HIV-1-infected adults. J Clin Invest 2008; 118:1085-98.
12. French RA, Broussard SR, Meier WA, Minshall C, Arkins S, Zachary JF, Dantzer R, Kelley KW. Age-associated loss of bone marrow hematopoietic cells is reversed by GH and accompanies thymic reconstitution. Endocrinology 2002; 143:690-9.
13. Franco JM, Rubio A, Martinez-Moya M, Leal M, Merchante E, Sanchez-Quijano A, Lissen E. T-cell repopulation and thymic volume in HIV-1-infected adult patients after highly active antiretroviral therapy. Blood 2002; 99:3702-6.
14. Ruiz-Hernandez R, Jou A, Cabrera C et al. Distribution of CD31 on CD4 T cells from cord blood, peripheral blood and tonsil at different stages of differentiation. Open Immunol J 2010; 3:19-26.
15. Massanella M, Puigdomenech I, Cabrera C et al. Antigp41 antibodies fail to block early events of virological synapses but inhibit HIV spread between T cells. AIDS 2009; 23:183-8.
16. Bofill M, Lipman M, McLaughlin JE, Johnson MA, Poulter LW. Changes in lung lymphocyte populations reflect those seen in peripheral blood in HIV-1 positive individuals. Eur Respir J 1998; 11:548-53.
17. Darwich L, Cabrera C, Romeu J et al. The magnitude of interferon-γ responses to human cytomegalovirus is predictive for HIV-1 disease progression. J Acquir Immune Defic Syndr 2008; 49:507-12.
18. De Rosa SC, Lu FX, Yu J et al. Vaccination in humans generates broad T cell cytokine responses. J Immunol 2004; 173:5372-80.
19. Plana M, Garcia F, Gallart T, Miro JM, Gatell JM. Lack of T-cell proliferative response to HIV-1 antigens after 1year of highly active antiretroviral treatment in early HIV-1 disease. Immunology study group of Spanish EARTH-1 Study. Lancet 1998; 352:1194-5.
20. Montefiori DC, Metch B, McElrath MJ, Self S, Weinhold KJ, Corey L. Demographic factors that influence the neutralizing antibody response in recipients of recombinant HIV-1 gp120 vaccines. J Infect Dis 2004; 11:1962-9.
21. Coligan JE. Commonly used detergents. Curr Protoc Protein Sci 2001; A1B1:A1B3 (online).
22. Haynes BF, Hale LP, Weinhold KJ et al. Analysis of the adult thymus in reconstitution of T lymphocytes in HIV-1 infection. J Clin Invest 1999; 103:453-60.
23. Shearer GM, Clerici M. Early T-helper cell defects in HIV infection. Aids 1991; 5:245-53.
24. Lee JC, Boechat MI, Belzer M et al. Thymic volume, T-cell populations, and parameters of thymopoiesis in adolescent and adult survivors of HIV infection acquired in infancy. AIDS 2006; 20:667-74.
25. Hansen BR, Kolte L, Haugaard SB et al. Improved thymic index, density and output in HIV-infected patients following low-dose growth hormone therapy: a placebo controlled study. AIDS 2009; 23:2123-31.
26. Castro P, Plana M, Gonzalez R et al. Influence of a vaccination schedule on viral load rebound and immune responses in successfully treated HIV-infected patients. AIDS Res Hum Retroviruses 2009; 25:1249-59.
27. Kimmig S, Przybylski GK, Schmidt CA, Laurisch K, Mowes B, Radbruch A, Thiel A. Two subsets of naive T helper cells with distinct T cell receptor excision circle content in human adult peripheral blood. J Exp Med 2002; 195:789-94.
28. + regulatory T cells. Eur J Immunol 2002; 32:1621-30.
29. + T cells. J Immunol 2009; 183:7919-30.
30. - NK cell subset and NK cell interferon-γ production during antiretroviral therapy for HIV-1: partial recovery by human growth hormone. Clin Exp Immunol 2003; 134:470-6.
31. + regulatory T cells control T-cell responses to human immunodeficiency virus and cytomegalovirus antigens. J Virol 2004; 78:2454-9.
32. Douek DC. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev 2003; 5:172-7.
33. Bofill M, Parkhouse RM. The increased CD38 expressed by lymphocytes infected with HIV-1 is a fully active NADase. Eur J Immunol 1999; 29:3583-7.